zenodorestricted
Safety and efficacy of Interferon y in Friedreich ataxia, using clinical and paraclinical indicators of disease
<p>The data shared in the Zenodo repository include clinical and instrumental data from a randomized clinical trial open label phase II in Friedreich's Ataxia patients that underwent a 6 months treatment with interferone gamma and 6 months follow-up. Permission to use the data will be given only on direct request, correspondence to Prof. Andrea Martinuzzi ( andrea.martinuzzi@lanostrafamiglia.it ).</p>
ShareScore
16/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 8
- Harmonization
- 4
- Access
- 0
- Reuse readiness
- 0
- Engagement
- 4
Topics
Dataset details
- Repository
- zenodo
- Published
- May 21, 2019
- License
- Not reported
- DOI
- 10.5281/zenodo.3143301
Scored with release 0.9.0
ScienceDex for faculty
Your academic CV and NIH biosketch
Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.